Stay updated on TEPEZZA Post-Marketing Requirement Study Clinical Trial

Sign up to get notified when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TEPEZZA Post-Marketing Requirement Study Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Locations section updated to include new site entries across the US and Europe (e.g., California, Colorado, London, Doubs, Rhône, Lombardy, Campania, Córdoba). Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T15:00:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. No content or structural changes are visible.
    Difference
    0.0%
    Check dated 2025-11-25T13:59:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the government funding operating status notice; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:22:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting updates with no changes to the study details, endpoints, eligibility, enrollment, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:22:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:49:35.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Added a new version label (v3.1.0) and removed several drug-safety topics (MedlinePlus Drug Safety, Substandard Drugs, Counterfeit Drugs, and the older version label v3.0.2), resulting in a narrower core content area focused on the updated version.
    Difference
    0.5%
    Check dated 2025-09-29T03:10:21.000Z thumbnail image

Stay in the know with updates to TEPEZZA Post-Marketing Requirement Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TEPEZZA Post-Marketing Requirement Study Clinical Trial page.